Psychedelic Psilocybin Mushrooms Give Long-Term Relief From Depressive Symptoms- Another Study Reveals

Psychedelic Psilocybin Mushrooms can provide long-term relief for depression; these plants can help to reduce anxiety and depression…
Psychedelic psilocybin mushrooms

Psychedelic Psilocybin Mushrooms can provide long-term relief for depression; these plants can help to reduce anxiety and depression in humans, according to another study. A previous study had revealed that two doses of psilocybin could significantly reduce major depressive symptoms in adults when combined with assisted psychotherapy.

In this small study, 24 adults participated and these adults were followed up for 24 weeks. The study consisted of two five-hour psilocybin therapy sessions and when the results were out, researchers at the Center for Psychedelic and Consciousness Research (CPCR) at Johns Hopkins School of Medicine were totally surprised.

The magnitude of the effect we saw was about four times larger than what clinical trials have shown for traditional antidepressants on the market.

Alan Davis, Ph.D., professor of psychiatry and behavioral sciences

The data from the U.S. Centers For Disease Control (CDC) revealed that tens of millions of adults have suffered from a chronic anxiety disorder at a point in their lifetime while one in every 6 adults will have depressive symptoms during some period in their life.

You can also read: Scientists Transform Plastic Waste Into Valuable Commodities

In this new study, the researchers analyzed if psilocybin could be effective enough to be used to treat standard depressive disorders, although it was already granted as a therapy for untreatable depression.

Because there are several types of major depressive disorders that may result in variation in how people respond to treatment, I was surprised that most of our study participants found the psilocybin treatment to be effective.

Roland Griffiths Ph.D., Director of the CPCR

In this study, 67% of the participants showed over 50% reduction in depression symptoms in the first week of follow-up and 71% in the fourth week of follow-up. Overall, after four weeks of treatment, 54% of participants were believed to be in remission, which means they are no longer suffering from depression.

Featured image source

Total
0
Shares
Related Posts